» Articles » PMID: 22383251

Investigations on the 4-quinolone-3-carboxylic Acid Motif Part 5: Modulation of the Physicochemical Profile of a Set of Potent and Selective Cannabinoid-2 Receptor Ligands Through a Bioisosteric Approach

Abstract

Three heterocyclic systems were selected as potential bioisosteres of the amide linker for a series of 1,6-disubstituted-4-quinolone-3-carboxamides, which are potent and selective CB2 ligands that exhibit poor water solubility, with the aim of improving their physicochemical profile and also of clarifying properties of importance for amide bond mimicry. Among the newly synthesized compounds, a 1,2,3-triazole derivative (1-(adamantan-1-yl)-4-[6-(furan-2-yl)-1,4-dihydro-4-oxo-1-pentylquinolin-3-yl]-1H-1,2,3-triazole) emerged as the most promising in terms of both physicochemical and pharmacodynamic properties. When assayed in vitro, this derivative exhibited inverse agonist activity, whereas, in the formalin test in mice, it produced analgesic effects antagonized by a well-established inverse agonist. Metabolic studies allowed the identification of a side chain hydroxylated derivative as its only metabolite, which, in its racemic form, still showed appreciable CB2 selectivity, but was 150-fold less potent than the parent compound.

Citing Articles

Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor.

Mugnaini C, Kostrzewa M, Casini M, Kumar P, Catallo V, Allara M Molecules. 2023; 28(13).

PMID: 37446625 PMC: 10343475. DOI: 10.3390/molecules28134958.


Rational drug design of CB2 receptor ligands: from 2012 to 2021.

Wu Y, Tang J, Zhang W, Zhuang C, Shi Y RSC Adv. 2022; 12(54):35242-35259.

PMID: 36540233 PMC: 9730932. DOI: 10.1039/d2ra05661e.


N-palmitoyl-D-glucosamine, a Natural Monosaccharide-Based Glycolipid, Inhibits TLR4 and Prevents LPS-Induced Inflammation and Neuropathic Pain in Mice.

Iannotta M, Belardo C, Trotta M, Iannotti F, Vitale R, Maisto R Int J Mol Sci. 2021; 22(3).

PMID: 33540826 PMC: 7867376. DOI: 10.3390/ijms22031491.


Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Kumari S, Carmona A, Tiwari A, Trippier P J Med Chem. 2020; 63(21):12290-12358.

PMID: 32686940 PMC: 7666045. DOI: 10.1021/acs.jmedchem.0c00530.


Catalyst-free assembly of giant tris(heteroaryl)methanes: synthesis of novel pharmacophoric triads and model sterically crowded tris(heteroaryl/aryl)methyl cation salts.

Abonia R, Gutierrez L, Insuasty B, Quiroga J, Laali K, Zhao C Beilstein J Org Chem. 2019; 15:642-654.

PMID: 30931006 PMC: 6423583. DOI: 10.3762/bjoc.15.60.


References
1.
Alsenz J, Kansy M . High throughput solubility measurement in drug discovery and development. Adv Drug Deliv Rev. 2007; 59(7):546-67. DOI: 10.1016/j.addr.2007.05.007. View

2.
Mach F, Montecucco F, Steffens S . Cannabinoid receptors in acute and chronic complications of atherosclerosis. Br J Pharmacol. 2007; 153(2):290-8. PMC: 2219535. DOI: 10.1038/sj.bjp.0707517. View

3.
Whiteside G, Lee G, Valenzano K . The role of the cannabinoid CB2 receptor in pain transmission and therapeutic potential of small molecule CB2 receptor agonists. Curr Med Chem. 2007; 14(8):917-36. DOI: 10.2174/092986707780363023. View

4.
Pasquini S, Ligresti A, Mugnaini C, Semeraro T, Cicione L, De Rosa M . Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands. J Med Chem. 2010; 53(16):5915-28. DOI: 10.1021/jm100123x. View

5.
Sarfaraz S, Adhami V, Syed D, Afaq F, Mukhtar H . Cannabinoids for cancer treatment: progress and promise. Cancer Res. 2008; 68(2):339-42. DOI: 10.1158/0008-5472.CAN-07-2785. View